AKTS

AKTIS ONCOLOGY INC

AKTS·01021M104·US·Common Stock-Activist

AKTS (AKTIS ONCOLOGY INC) is held by 49 institutional investors as of Q1 2026. Largest holders: WELLINGTON MANAGEMENT GROUP LLP ($41.5M), BlackRock, Inc. ($37.8M), RTW INVESTMENTS, LP ($28.5M). Net institutional sentiment: Bullish.

49
Holders
(2 Elite)
$285M
Total Value
100% (49)
Consensus
49 buying - 0 selling
13F: Insider & Congress:
AKTS

Smart Money Verdict

View all
Held by 49 funds
2 elite

Who's Trading

InsiderCACzibere AkosSell $401KJul 8, 2026
InsiderRSRon-Bigger ShulamitSell $429KJul 8, 2026
InsiderCACzibere AkosSell $862KJul 8, 2026
InsiderRSRon-Bigger ShulamitSell $838KJul 8, 2026
InsiderRSRon-Bigger ShulamitSell $121KJul 8, 2026
InsiderCACzibere AkosSell $125KJul 8, 2026
ActivistBOBlue Owl Capital Holdings LP5.9%May 14, 2026
ActivistMBMPM BIOVENTURES 2018, L.P.7.4%Jan 20, 2026
ActivistECEcoR1 Capital, LLC9.1%Jan 20, 2026
ActivistELEli Lilly and Company11.9%Jan 15, 2026

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
2.3M$41.5M0.0%+34.88%
40
New
2.1M$37.8M0.0%+34.88%
40
New
1.6M$28.5M0.3%+34.88%
48
New
1.6M$28M0.0%+34.88%
40
New
1.5M$26.9M0.3%+34.88%
47
New
1.5M$26M0.0%+34.88%
40
New
996,351$17.8M0.1%+34.88%
47
New
833,913$14.9M0.0%+34.88%
39
New
491,936$8.8M0.0%+34.88%
38
New
428,253$7.7M0.0%+34.88%
38
New
386,379$6.9M0.0%+34.88%
38
New
353,263$6.3M0.0%+34.88%
38
New
290,000$5.2M0.0%+34.88%
37
New
162,017$2.9M0.0%+34.88%
36
New
150,000$2.7M0.0%+34.88%
36
New
149,476$2.7M0.0%+34.88%
36
New
127,395$2.3M0.0%+34.88%
36
New
120,322$2.2M0.0%+34.88%
36
New
102,925$1.8M0.0%+34.88%
36
New
100,962$1.8M0.0%+34.88%
36

Showing 1-20 of 49

1 / 3
AKTSAKTSAKTIS ONCOLOGY INC

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used